Japan Tissue Engineering Co., Ltd. provided earnings guidance for the year ending March 31, 2025. For the year, the company expects net sales to be JPY 2,944 million, Operating income to be JPY 120 million, Net profit to be JPY 87 million or JPY 2.14 per share.
Japan Tissue Engineering Co., Ltd.
Equities
7774
JP3389610001
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
596 JPY | +4.38% | -4.33% | +17.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.79% | 156M | |
+11.76% | 127B | |
-5.10% | 11.34B | |
+4.02% | 9.11B | |
+38.12% | 5.53B | |
-23.70% | 4.61B | |
+8.55% | 3.45B | |
-6.44% | 2.87B | |
-5.85% | 2.1B | |
-11.84% | 2.08B |
- Stock Market
- Equities
- 7774 Stock
- News Japan Tissue Engineering Co., Ltd.
- Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2025